Eli Lilly (LLY) vs Alphabet (GOOGL)

A structured, side-by-side research starting point for Eli Lilly and Alphabet — price history, key metrics, and the questions great investors would ask about each. Educational only.

Price Charts

Eli LillyLLY · NYSE
以表格查看近期價格
日期收盘价
2026-11-09$1411.95
2026-11-06$1354.00
2026-11-05$1364.73
2026-11-04$1417.99
2026-11-03$1409.38
2026-11-02$1410.99
2026-10-30$1417.54
2026-10-29$1373.70
2026-10-28$1288.30
2026-10-27$1281.91
AlphabetGOOGL · NASDAQ
以表格查看近期價格
日期收盘价
2026-11-06$284.78
2026-11-05$282.57
2026-11-04$288.93
2026-11-03$280.03
2026-11-02$278.99
2026-10-30$279.84
2026-10-29$283.82
2026-10-28$324.89
2026-10-27$320.58
2026-10-26$316.80

Key Metrics, Side by Side

MetricLLYGOOGL
SectorPharmaceuticalsInternet & Advertising
ListedNYSENASDAQ
Business mixDiabetes, Obesity, Oncology, ImmunologySearch, YouTube, Cloud, Android
Moat typePatents + pipeline + manufacturingNetwork effects + data scale
Typical valuation profileHigh growth, premium multipleQuality growth at a reasonable multiple
Capital returnsGrowing dividend + buybacksBuybacks + new dividend

Approximate reference figures for education. Always verify against the latest filings before any decision.

How the Masters Would Frame Each

The same investing lenses, applied to both companies. Use them as a checklist — not as buy or sell signals.

Eli Lilly (LLY)
InvestorKey question
Warren BuffettHow durable are the patents and franchises, and what happens at patent expiry?
Peter LynchDoes the GLP-1 growth story justify a premium multiple?
Howard MarksHow much obesity-drug optimism is already priced in?
Benjamin GrahamWhat protection exists if pipeline trials disappoint or competition intensifies?
Alphabet (GOOGL)
InvestorKey question
Warren BuffettDoes Search keep its toll-booth economics in an AI world?
Peter LynchIs the multiple reasonable given ad and cloud growth?
Charlie MungerIs management investing the cash flows wisely, or empire-building?
Benjamin GrahamWhat downside protection exists if AI disrupts Search ads?

More Comparisons

Not financial advice

This page is an educational research starting point built from public information. It is not investment advice, not a recommendation to buy or sell, and figures may be delayed or approximate. Always do your own research.

Compare any two stocks with master frameworks inside the app:

Get the App